Use sovereign rights to grant compulsory license for vaccine, medicines: SJM to govt
SECTIONS
Share
Synopsis
“We understand that the government needs to use the public health safeguards in the Patents Act and permit more companies to produce these medicines in the coming days,” Mahajan said in the statement, explaining that India would require around 2 billion doses of vaccine in the next 6 months and there is a need to multiply these efforts.
AFP
The SJM has launched a “Digital Signature Campaign for Universal Access of Vaccine and Medicines”.
Swadeshi Jagran Manch, an affiliate of the Rashtriya Swayamsevak Sangh on Monday suggested the government to use its sovereign rights to grant the compulsory license to other pharma manufacturers to produce vaccine and medicines to fight the Covid-19 pandemic. Pushing for the involvement of more companies in manufacturing vaccines and medicines like Remdesivir, it termed patent protection as a “major barrier” to the generic
Walk the talk on TRIPS waiver
Updated:
Updated:
The government should offer Covaxin’s technology to domestic pharmaceutical companies and foreign corporations
Share Article
The government should offer Covaxin’s technology to domestic pharmaceutical companies and foreign corporations
Member countries of the World Trade Organization (WTO) are under an obligation to ensure that their domestic intellectual property rights (IPR) laws conform to the requirements of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement. When the pandemic hit the globe, India and South Africa piloted the proposal to waive key provisions of the TRIPS agreement on COVID-19 vaccines, drugs, therapeutics, and related technologies. The core idea is that IPRs such as patents should not become barriers in scaling up production of medical products essential to combat COVID-19. The TRIPS waiver proposal, now backed by the U.S., is essential because it would give immunity to member coun
China also promised to supply 10 million vaccines to COVAX. (File)
Beijing:
China, which is actively pursuing vaccine diplomacy, said on Monday that it is supportive of India and South Africa s proposal for a temporary waiver of Trade-Related Aspects of Intellectual Property Rights (TRIPS) for coronavirus vaccines, asserting that Beijing will back all actions that are conducive to the developing countries fight against the pandemic.
India and South Africa called for TRIPS waiver of certain intellectual property provisions of COVID-19 vaccines in a communication to the World Trade Organization (WTO) in October last year so that people in developing countries get access to life-saving vaccines and therapeutics as soon as possible.
Vaccine waivers alone can’t solve India’s vaccine crisis
But they might help
Share this story
India never should have been in this position. The government is currently engaged in international disputes over vaccine waivers and intellectual property rights, while a horrific and record-setting surge of COVID-19 cases continues to devastate its population. The country’s recent vaccine policies opening vaccination for all above the age of 18 while reeling under severe shortage, allowing the private sectors to sell the vaccine at market prices, and leaving the states to procure vaccines themselves have been strongly criticized by public health experts and its Supreme Court.
Letter from 141 Scholars to USTR, re: United States Facilitation of the TRIPS Waiver infojustice.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infojustice.org Daily Mail and Mail on Sunday newspapers.